Clinical Trials Browser

Prostatic Neoplasms × pexidartinib × Clear all

NCT01499043 2020-03-04

Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC)

Phase 2 Terminated

6 enrolled 6 charts

Prostatic Neoplasms